

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.08047992 |
| 2 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.77877355 |
| 3 | negative regulation of cell killing (GO:0031342) | 4.77877355 |
| 4 | pharyngeal system development (GO:0060037) | 4.77576414 |
| 5 | negative regulation of fatty acid transport (GO:2000192) | 4.74422803 |
| 6 | regulation of cell proliferation involved in kidney development (GO:1901722) | 4.71166073 |
| 7 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 4.60913596 |
| 8 | interleukin-1-mediated signaling pathway (GO:0070498) | 4.51858457 |
| 9 | regulation of gamma-delta T cell activation (GO:0046643) | 4.47567029 |
| 10 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.46966541 |
| 11 | tolerance induction (GO:0002507) | 4.42034427 |
| 12 | cellular response to follicle-stimulating hormone stimulus (GO:0071372) | 4.37715044 |
| 13 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.14106236 |
| 14 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.14106236 |
| 15 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.14106236 |
| 16 | modulation by symbiont of host immune response (GO:0052553) | 4.14106236 |
| 17 | positive regulation by symbiont of host defense response (GO:0052509) | 4.14106236 |
| 18 | modulation by symbiont of host defense response (GO:0052031) | 4.14106236 |
| 19 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.11072657 |
| 20 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.09547694 |
| 21 | regulation of cardioblast proliferation (GO:0003264) | 4.04124132 |
| 22 | regulation of secondary heart field cardioblast proliferation (GO:0003266) | 4.04124132 |
| 23 | one-carbon compound transport (GO:0019755) | 4.03889631 |
| 24 | positive regulation of glomerulus development (GO:0090193) | 3.98785952 |
| 25 | glucuronate metabolic process (GO:0019585) | 3.98043017 |
| 26 | uronic acid metabolic process (GO:0006063) | 3.98043017 |
| 27 | response to nitrosative stress (GO:0051409) | 3.85158445 |
| 28 | germinal center formation (GO:0002467) | 3.83167628 |
| 29 | regulation of chemokine secretion (GO:0090196) | 3.82939137 |
| 30 | macrophage activation involved in immune response (GO:0002281) | 3.82191779 |
| 31 | cellular extravasation (GO:0045123) | 3.79512701 |
| 32 | detection of other organism (GO:0098543) | 3.74588639 |
| 33 | cellular glucuronidation (GO:0052695) | 3.74318022 |
| 34 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.72685684 |
| 35 | cellular response to antibiotic (GO:0071236) | 3.72422310 |
| 36 | thrombin receptor signaling pathway (GO:0070493) | 3.71909046 |
| 37 | response to peptidoglycan (GO:0032494) | 3.70661063 |
| 38 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.69011327 |
| 39 | renal absorption (GO:0070293) | 3.67836852 |
| 40 | cell proliferation involved in kidney development (GO:0072111) | 3.56982328 |
| 41 | detection of bacterium (GO:0016045) | 3.55154939 |
| 42 | negative regulation of interleukin-12 production (GO:0032695) | 3.48296032 |
| 43 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.46732629 |
| 44 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.44256525 |
| 45 | hormone catabolic process (GO:0042447) | 3.44126862 |
| 46 | xenobiotic catabolic process (GO:0042178) | 3.44040688 |
| 47 | ear development (GO:0043583) | 3.43312357 |
| 48 | negative thymic T cell selection (GO:0045060) | 3.41076046 |
| 49 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.40746202 |
| 50 | energy homeostasis (GO:0097009) | 3.40697656 |
| 51 | desmosome organization (GO:0002934) | 3.36614751 |
| 52 | positive thymic T cell selection (GO:0045059) | 3.35847374 |
| 53 | leukocyte aggregation (GO:0070486) | 3.34674190 |
| 54 | response to progesterone (GO:0032570) | 3.30914761 |
| 55 | atrioventricular valve morphogenesis (GO:0003181) | 3.29267266 |
| 56 | NIK/NF-kappaB signaling (GO:0038061) | 3.24771901 |
| 57 | negative T cell selection (GO:0043383) | 3.24735109 |
| 58 | cellular response to gonadotropin stimulus (GO:0071371) | 3.24399004 |
| 59 | regulation of glomerulus development (GO:0090192) | 3.24040522 |
| 60 | myoblast migration (GO:0051451) | 3.23470338 |
| 61 | negative regulation of glycogen biosynthetic process (GO:0045719) | 3.22413684 |
| 62 | endoderm formation (GO:0001706) | 3.21679260 |
| 63 | B cell receptor signaling pathway (GO:0050853) | 3.21005415 |
| 64 | interferon-gamma secretion (GO:0072643) | 3.20802355 |
| 65 | regulation of phospholipase A2 activity (GO:0032429) | 3.20720662 |
| 66 | metanephric mesenchyme development (GO:0072075) | 3.20468669 |
| 67 | * skeletal muscle cell differentiation (GO:0035914) | 3.20044155 |
| 68 | neutrophil activation involved in immune response (GO:0002283) | 3.17727229 |
| 69 | detection of external biotic stimulus (GO:0098581) | 3.15538178 |
| 70 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 3.15353617 |
| 71 | cellular response to type I interferon (GO:0071357) | 3.15317718 |
| 72 | type I interferon signaling pathway (GO:0060337) | 3.15317718 |
| 73 | response to type I interferon (GO:0034340) | 3.15002071 |
| 74 | endocardial cushion morphogenesis (GO:0003203) | 3.14294538 |
| 75 | response to follicle-stimulating hormone (GO:0032354) | 3.14226736 |
| 76 | immunoglobulin mediated immune response (GO:0016064) | 3.14048997 |
| 77 | detection of molecule of bacterial origin (GO:0032490) | 3.14048073 |
| 78 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.13292135 |
| 79 | endothelial cell chemotaxis (GO:0035767) | 3.12535791 |
| 80 | gland morphogenesis (GO:0022612) | 3.10517303 |
| 81 | defense response to protozoan (GO:0042832) | 3.09242103 |
| 82 | T cell migration (GO:0072678) | 3.08442123 |
| 83 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.04610382 |
| 84 | peptide catabolic process (GO:0043171) | 3.04159412 |
| 85 | response to interleukin-15 (GO:0070672) | 3.02614103 |
| 86 | negative regulation of T cell mediated immunity (GO:0002710) | 3.02078206 |
| 87 | cell differentiation involved in metanephros development (GO:0072202) | 3.00063223 |
| 88 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.96757293 |
| 89 | thymic T cell selection (GO:0045061) | 2.96299216 |
| 90 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.96064511 |
| 91 | response to host immune response (GO:0052572) | 2.96064511 |
| 92 | response to protozoan (GO:0001562) | 2.95780752 |
| 93 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.95234084 |
| 94 | T cell selection (GO:0045058) | 2.95036238 |
| 95 | regulation of regulatory T cell differentiation (GO:0045589) | 2.93574175 |
| 96 | positive T cell selection (GO:0043368) | 2.93199013 |
| 97 | toxin transport (GO:1901998) | 2.93070121 |
| 98 | glomerulus development (GO:0032835) | 2.93014622 |
| 99 | nucleotide transmembrane transport (GO:1901679) | 2.92311624 |
| 100 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 2.91775903 |
| 101 | detection of biotic stimulus (GO:0009595) | 2.89900110 |
| 102 | neutrophil activation (GO:0042119) | 2.89857254 |
| 103 | regulation of protein sumoylation (GO:0033233) | 2.89109315 |
| 104 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.87320784 |
| 105 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.85333124 |
| 106 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.85333124 |
| 107 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 2.83545835 |
| 108 | cellular response to interleukin-15 (GO:0071350) | 2.83360304 |
| 109 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.82898338 |
| 110 | radial glial cell differentiation (GO:0060019) | 2.82507270 |
| 111 | microglial cell activation (GO:0001774) | 2.81718842 |
| 112 | negative regulation of interleukin-6 production (GO:0032715) | 2.80961745 |
| 113 | B cell homeostasis (GO:0001782) | 2.80203026 |
| 114 | neutrophil mediated immunity (GO:0002446) | 2.79794888 |
| 115 | positive regulation of positive chemotaxis (GO:0050927) | 2.79594369 |
| 116 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.79258804 |
| 117 | regulation of T cell tolerance induction (GO:0002664) | 2.78323265 |
| 118 | interferon-gamma production (GO:0032609) | 2.77689261 |
| 119 | response to host (GO:0075136) | 2.77500872 |
| 120 | response to host defenses (GO:0052200) | 2.77500872 |
| 121 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.77500872 |
| 122 | T-helper 1 type immune response (GO:0042088) | 2.77489769 |
| 123 | granulocyte activation (GO:0036230) | 2.75814478 |
| 124 | kidney mesenchyme development (GO:0072074) | 2.75272336 |
| 125 | positive regulation of B cell differentiation (GO:0045579) | 2.74148650 |
| 126 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.74140714 |
| 127 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.74043794 |
| 128 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.73209137 |
| 129 | lipoxygenase pathway (GO:0019372) | 2.72777432 |
| 130 | regulation of tolerance induction (GO:0002643) | 2.71217784 |
| 131 | mesenchyme morphogenesis (GO:0072132) | 2.70554975 |
| 132 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.70341035 |
| 133 | regulation of positive chemotaxis (GO:0050926) | 2.69937279 |
| 134 | positive regulation of receptor recycling (GO:0001921) | 2.69112048 |
| 135 | regulation of germinal center formation (GO:0002634) | 2.68079749 |
| 136 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.67971418 |
| 137 | positive regulation of cholesterol efflux (GO:0010875) | 2.67878693 |
| 138 | negative regulation of keratinocyte proliferation (GO:0010839) | 2.67507783 |
| 139 | regulation of B cell differentiation (GO:0045577) | 2.66531024 |
| 140 | cellular response to toxic substance (GO:0097237) | 2.66241314 |
| 141 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 2.66155119 |
| 142 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 2.66155119 |
| 143 | negative regulation of protein autophosphorylation (GO:0031953) | 2.66058184 |
| 144 | response to gonadotropin (GO:0034698) | 2.65816029 |
| 145 | regulation of antigen processing and presentation (GO:0002577) | 2.65272213 |
| 146 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.65075166 |
| 147 | regulation of interleukin-8 secretion (GO:2000482) | 2.64864697 |
| 148 | positive regulation of interleukin-2 production (GO:0032743) | 2.64597154 |
| 149 | myeloid dendritic cell differentiation (GO:0043011) | 2.62869972 |
| 150 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.62160923 |
| 151 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 2.61775787 |
| 152 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.61315641 |
| 153 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.61315641 |
| 154 | negative regulation of glycogen metabolic process (GO:0070874) | 2.60904112 |
| 155 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.59504461 |
| 156 | myeloid cell activation involved in immune response (GO:0002275) | 2.59413970 |
| 157 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.59140574 |
| 158 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.58771742 |
| 159 | facial nerve structural organization (GO:0021612) | 2.56566174 |
| 160 | induction of positive chemotaxis (GO:0050930) | 2.56269213 |
| 161 | G-protein coupled purinergic receptor signaling pathway (GO:0035588) | 2.55334773 |
| 162 | negative regulation of innate immune response (GO:0045824) | 2.55324316 |
| 163 | positive regulation of interferon-alpha production (GO:0032727) | 2.55144818 |
| 164 | response to increased oxygen levels (GO:0036296) | 2.53820972 |
| 165 | response to hyperoxia (GO:0055093) | 2.53820972 |
| 166 | positive regulation of T cell chemotaxis (GO:0010820) | 2.52441824 |
| 167 | regulation of T cell chemotaxis (GO:0010819) | 2.52441824 |
| 168 | phenylpropanoid metabolic process (GO:0009698) | 2.52289446 |
| 169 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.51911997 |
| 170 | androgen biosynthetic process (GO:0006702) | 2.50237013 |
| 171 | viral protein processing (GO:0019082) | 2.49586830 |
| 172 | T-helper cell differentiation (GO:0042093) | 2.49438364 |
| 173 | negative regulation of systemic arterial blood pressure (GO:0003085) | 2.46094296 |
| 174 | regulation of skeletal muscle contraction (GO:0014819) | 2.45506007 |
| 175 | L-ascorbic acid metabolic process (GO:0019852) | 2.44705658 |
| 176 | positive regulation of chemokine secretion (GO:0090197) | 2.44669730 |
| 177 | response to gravity (GO:0009629) | 2.44583082 |
| 178 | face development (GO:0060324) | 2.43704772 |
| 179 | response to muramyl dipeptide (GO:0032495) | 2.43367193 |
| 180 | lung lobe morphogenesis (GO:0060463) | 2.43052191 |
| 181 | relaxation of cardiac muscle (GO:0055119) | 2.42355002 |
| 182 | mitotic cell cycle arrest (GO:0071850) | 2.42146782 |
| 183 | positive regulation of interleukin-8 secretion (GO:2000484) | 2.41869107 |
| 184 | generation of neurons (GO:0048699) | 2.41658701 |
| 185 | regulation of toll-like receptor 4 signaling pathway (GO:0034143) | 2.41615129 |
| 186 | negative regulation of JUN kinase activity (GO:0043508) | 2.40954365 |
| 187 | negative regulation of osteoblast proliferation (GO:0033689) | 2.40905144 |
| 188 | ER overload response (GO:0006983) | 2.39168119 |
| 189 | macrophage activation (GO:0042116) | 2.38224319 |
| 190 | positive regulation of actin filament depolymerization (GO:0030836) | 2.37289929 |
| 191 | negative regulation of cAMP-mediated signaling (GO:0043951) | 2.36607355 |
| 192 | cyclooxygenase pathway (GO:0019371) | 2.36262695 |
| 193 | positive regulation of kidney development (GO:0090184) | 2.35830125 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.38779330 |
| 2 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 4.74190305 |
| 3 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.30411890 |
| 4 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.95197828 |
| 5 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 3.65057278 |
| 6 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.39024594 |
| 7 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 3.28541522 |
| 8 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 2.93199127 |
| 9 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 2.84952554 |
| 10 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 2.84952554 |
| 11 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 2.84952554 |
| 12 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.82456229 |
| 13 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.80305595 |
| 14 | * SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.76957370 |
| 15 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.71886405 |
| 16 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.68201563 |
| 17 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.60404408 |
| 18 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.40777712 |
| 19 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 2.27647068 |
| 20 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.26661070 |
| 21 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 2.23583942 |
| 22 | MYC_22102868_ChIP-Seq_BL_Human | 2.22252069 |
| 23 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.20156974 |
| 24 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.19430435 |
| 25 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.19305713 |
| 26 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.17919503 |
| 27 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.17048585 |
| 28 | * MAF_26560356_Chip-Seq_TH1_Human | 2.12995129 |
| 29 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.10837104 |
| 30 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 2.07768870 |
| 31 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.05950695 |
| 32 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.02869701 |
| 33 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.98201272 |
| 34 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.97837641 |
| 35 | * RUNX_20019798_ChIP-Seq_JUKART_Human | 1.95016045 |
| 36 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.93112437 |
| 37 | * MYB_26560356_Chip-Seq_TH1_Human | 1.88062810 |
| 38 | UTX_26944678_Chip-Seq_JUKART_Human | 1.82387335 |
| 39 | SPI1_23127762_ChIP-Seq_K562_Human | 1.73599271 |
| 40 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.69837317 |
| 41 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.69658756 |
| 42 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.66098134 |
| 43 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.64209159 |
| 44 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.63350578 |
| 45 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.62219060 |
| 46 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.62219060 |
| 47 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.61568964 |
| 48 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.60532716 |
| 49 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.60486020 |
| 50 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.59118544 |
| 51 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.58807155 |
| 52 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.58708820 |
| 53 | TP53_16413492_ChIP-PET_HCT116_Human | 1.58590194 |
| 54 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.58449204 |
| 55 | * GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.57500752 |
| 56 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.57304167 |
| 57 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.55194515 |
| 58 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.54066977 |
| 59 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.52515912 |
| 60 | * TP53_18474530_ChIP-ChIP_U2OS_Human | 1.46102834 |
| 61 | MAF_26560356_Chip-Seq_TH2_Human | 1.45131816 |
| 62 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.44684994 |
| 63 | CJUN_26792858_Chip-Seq_BT549_Human | 1.42603486 |
| 64 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.41754270 |
| 65 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.39688956 |
| 66 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.38913733 |
| 67 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.38737685 |
| 68 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.36318895 |
| 69 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.35133424 |
| 70 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.34400491 |
| 71 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.31451955 |
| 72 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.28816890 |
| 73 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.28816890 |
| 74 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.28014035 |
| 75 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.27115568 |
| 76 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.23932342 |
| 77 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.23770193 |
| 78 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.23574166 |
| 79 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.22193970 |
| 80 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.22076745 |
| 81 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.19721529 |
| 82 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.18959482 |
| 83 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.18811316 |
| 84 | * SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.17843056 |
| 85 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.17835419 |
| 86 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.16638440 |
| 87 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.16530568 |
| 88 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.14583527 |
| 89 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.14276473 |
| 90 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.14250181 |
| 91 | RXR_22108803_ChIP-Seq_LS180_Human | 1.13436050 |
| 92 | GATA1_22025678_ChIP-Seq_K562_Human | 1.12259879 |
| 93 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.11379612 |
| 94 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.11060564 |
| 95 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.10966361 |
| 96 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.10215842 |
| 97 | * CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.10114838 |
| 98 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.09372029 |
| 99 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.07013989 |
| 100 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.06410895 |
| 101 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.05565504 |
| 102 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.04707694 |
| 103 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.04386817 |
| 104 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.04351863 |
| 105 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.02177817 |
| 106 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.00738105 |
| 107 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.99905057 |
| 108 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.99312060 |
| 109 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.97767655 |
| 110 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.97195182 |
| 111 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.96090567 |
| 112 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.95994445 |
| 113 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.91804604 |
| 114 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.91801657 |
| 115 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.91586603 |
| 116 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.91071715 |
| 117 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.89193483 |
| 118 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.89141936 |
| 119 | * TP63_23658742_ChIP-Seq_EP156T_Human | 0.88427836 |
| 120 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.88258268 |
| 121 | * RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.88059832 |
| 122 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.87613677 |
| 123 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.87580075 |
| 124 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.87056139 |
| 125 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.86979629 |
| 126 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.86510327 |
| 127 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.84092443 |
| 128 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.83616939 |
| 129 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.83415117 |
| 130 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.82951267 |
| 131 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.82735740 |
| 132 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.82727188 |
| 133 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.82656577 |
| 134 | GF1B_26923725_Chip-Seq_HPCs_Mouse | 0.81600694 |
| 135 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.81286108 |
| 136 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.80726134 |
| 137 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.80715630 |
| 138 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.80220330 |
| 139 | MYB_26560356_Chip-Seq_TH2_Human | 0.79839460 |
| 140 | * ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.79701782 |
| 141 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.79646169 |
| 142 | * EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.79500841 |
| 143 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.78907112 |
| 144 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.78856499 |
| 145 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.77211292 |
| 146 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.77149155 |
| 147 | * UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.76774666 |
| 148 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.76577243 |
| 149 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.76417067 |
| 150 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.75628939 |
| 151 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.75551154 |
| 152 | * GATA1_19941826_ChIP-Seq_K562_Human | 0.74733837 |
| 153 | KLF5_25053715_ChIP-Seq_YYC3_Human | 0.74527460 |
| 154 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.73583712 |
| 155 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.73360004 |
| 156 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.73096743 |
| 157 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.72047354 |
| 158 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.71819984 |
| 159 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.71304651 |
| 160 | * LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.71293671 |
| 161 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 0.70772775 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002877_abnormal_melanocyte_morpholog | 4.58941184 |
| 2 | MP0002254_reproductive_system_inflammat | 4.42237991 |
| 3 | MP0003303_peritoneal_inflammation | 4.21222098 |
| 4 | MP0002009_preneoplasia | 3.38650948 |
| 5 | MP0001346_abnormal_lacrimal_gland | 3.31079732 |
| 6 | MP0008789_abnormal_olfactory_epithelium | 3.30388849 |
| 7 | MP0000678_abnormal_parathyroid_gland | 2.97939316 |
| 8 | MP0005394_taste/olfaction_phenotype | 2.84958895 |
| 9 | MP0005499_abnormal_olfactory_system | 2.84958895 |
| 10 | MP0000685_abnormal_immune_system | 2.78518955 |
| 11 | MP0003724_increased_susceptibility_to | 2.71388212 |
| 12 | MP0002132_abnormal_respiratory_system | 2.64780631 |
| 13 | MP0005646_abnormal_pituitary_gland | 2.56295065 |
| 14 | MP0009785_altered_susceptibility_to | 2.50846597 |
| 15 | MP0005025_abnormal_response_to | 2.48914123 |
| 16 | MP0003828_pulmonary_edema | 2.35515821 |
| 17 | MP0002420_abnormal_adaptive_immunity | 2.30628513 |
| 18 | MP0001819_abnormal_immune_cell | 2.27500432 |
| 19 | MP0010030_abnormal_orbit_morphology | 2.22071585 |
| 20 | MP0000613_abnormal_salivary_gland | 2.14626068 |
| 21 | MP0002138_abnormal_hepatobiliary_system | 2.09165958 |
| 22 | MP0009379_abnormal_foot_pigmentation | 2.02396781 |
| 23 | MP0009278_abnormal_bone_marrow | 1.93969030 |
| 24 | MP0003941_abnormal_skin_development | 1.90813044 |
| 25 | MP0002060_abnormal_skin_morphology | 1.83411374 |
| 26 | MP0004883_abnormal_blood_vessel | 1.83138249 |
| 27 | MP0006082_CNS_inflammation | 1.81445195 |
| 28 | MP0002277_abnormal_respiratory_mucosa | 1.78890173 |
| 29 | MP0004510_myositis | 1.77747606 |
| 30 | MP0010368_abnormal_lymphatic_system | 1.77351808 |
| 31 | MP0000716_abnormal_immune_system | 1.76844766 |
| 32 | MP0002398_abnormal_bone_marrow | 1.74220534 |
| 33 | MP0004264_abnormal_extraembryonic_tissu | 1.73305525 |
| 34 | MP0000762_abnormal_tongue_morphology | 1.72036574 |
| 35 | MP0002098_abnormal_vibrissa_morphology | 1.70684680 |
| 36 | MP0000566_synostosis | 1.65652055 |
| 37 | MP0009333_abnormal_splenocyte_physiolog | 1.64831370 |
| 38 | MP0008004_abnormal_stomach_pH | 1.64011883 |
| 39 | MP0001853_heart_inflammation | 1.55491834 |
| 40 | MP0005310_abnormal_salivary_gland | 1.50489856 |
| 41 | MP0003763_abnormal_thymus_physiology | 1.50227792 |
| 42 | MP0002405_respiratory_system_inflammati | 1.49586328 |
| 43 | MP0009780_abnormal_chondrocyte_physiolo | 1.49234095 |
| 44 | MP0001873_stomach_inflammation | 1.48303936 |
| 45 | MP0000689_abnormal_spleen_morphology | 1.45521102 |
| 46 | MP0009764_decreased_sensitivity_to | 1.45112944 |
| 47 | MP0001919_abnormal_reproductive_system | 1.40750415 |
| 48 | MP0002722_abnormal_immune_system | 1.39963485 |
| 49 | MP0000049_abnormal_middle_ear | 1.37607524 |
| 50 | MP0000467_abnormal_esophagus_morphology | 1.34849550 |
| 51 | MP0003866_abnormal_defecation | 1.34305927 |
| 52 | MP0002429_abnormal_blood_cell | 1.34098999 |
| 53 | MP0002148_abnormal_hypersensitivity_rea | 1.31910461 |
| 54 | MP0004947_skin_inflammation | 1.30892749 |
| 55 | MP0000703_abnormal_thymus_morphology | 1.29617289 |
| 56 | MP0008469_abnormal_protein_level | 1.29201153 |
| 57 | MP0005023_abnormal_wound_healing | 1.25253924 |
| 58 | MP0001188_hyperpigmentation | 1.24841978 |
| 59 | MP0009840_abnormal_foam_cell | 1.24327453 |
| 60 | MP0005464_abnormal_platelet_physiology | 1.23866232 |
| 61 | MP0004381_abnormal_hair_follicle | 1.22422022 |
| 62 | MP0003300_gastrointestinal_ulcer | 1.21941052 |
| 63 | MP0008007_abnormal_cellular_replicative | 1.21308255 |
| 64 | MP0003172_abnormal_lysosome_physiology | 1.20957940 |
| 65 | MP0003453_abnormal_keratinocyte_physiol | 1.19871043 |
| 66 | MP0003045_fibrosis | 1.17670586 |
| 67 | MP0003656_abnormal_erythrocyte_physiolo | 1.16832049 |
| 68 | MP0008995_early_reproductive_senescence | 1.16528657 |
| 69 | MP0005166_decreased_susceptibility_to | 1.15610064 |
| 70 | MP0001835_abnormal_antigen_presentation | 1.11193079 |
| 71 | MP0001984_abnormal_olfaction | 1.10900867 |
| 72 | MP0000383_abnormal_hair_follicle | 1.10814183 |
| 73 | MP0003191_abnormal_cellular_cholesterol | 1.10360450 |
| 74 | MP0001790_abnormal_immune_system | 1.10139971 |
| 75 | MP0005387_immune_system_phenotype | 1.10139971 |
| 76 | MP0001270_distended_abdomen | 1.09923371 |
| 77 | MP0005000_abnormal_immune_tolerance | 1.06612931 |
| 78 | MP0003436_decreased_susceptibility_to | 1.06058022 |
| 79 | MP0005164_abnormal_response_to | 1.05441360 |
| 80 | MP0003786_premature_aging | 1.05346654 |
| 81 | MP0005167_abnormal_blood-brain_barrier | 1.04553208 |
| 82 | MP0002090_abnormal_vision | 1.03890113 |
| 83 | MP0004782_abnormal_surfactant_physiolog | 1.03678252 |
| 84 | MP0005058_abnormal_lysosome_morphology | 1.02458030 |
| 85 | MP0001879_abnormal_lymphatic_vessel | 1.01810041 |
| 86 | MP0002233_abnormal_nose_morphology | 1.01097168 |
| 87 | MP0000858_altered_metastatic_potential | 1.00890042 |
| 88 | MP0005390_skeleton_phenotype | 1.00740667 |
| 89 | MP0005451_abnormal_body_composition | 1.00454124 |
| 90 | MP0006292_abnormal_olfactory_placode | 1.00253846 |
| 91 | MP0008961_abnormal_basal_metabolism | 0.99336496 |
| 92 | MP0002166_altered_tumor_susceptibility | 0.98288609 |
| 93 | MP0000372_irregular_coat_pigmentation | 0.96879552 |
| 94 | MP0001533_abnormal_skeleton_physiology | 0.95436393 |
| 95 | MP0005508_abnormal_skeleton_morphology | 0.95287459 |
| 96 | MP0006072_abnormal_retinal_apoptosis | 0.95048275 |
| 97 | MP0001216_abnormal_epidermal_layer | 0.94807295 |
| 98 | MP0000249_abnormal_blood_vessel | 0.94596913 |
| 99 | MP0001851_eye_inflammation | 0.93956492 |
| 100 | MP0008260_abnormal_autophagy | 0.93697806 |
| 101 | MP0002419_abnormal_innate_immunity | 0.92957191 |
| 102 | MP0003091_abnormal_cell_migration | 0.90471188 |
| 103 | MP0003279_aneurysm | 0.90004898 |
| 104 | MP0003943_abnormal_hepatobiliary_system | 0.88886147 |
| 105 | MP0000465_gastrointestinal_hemorrhage | 0.88782733 |
| 106 | MP0000343_altered_response_to | 0.87920931 |
| 107 | MP0001191_abnormal_skin_condition | 0.87550810 |
| 108 | MP0010386_abnormal_urinary_bladder | 0.85507694 |
| 109 | MP0005408_hypopigmentation | 0.85470932 |
| 110 | MP0002006_tumorigenesis | 0.85400940 |
| 111 | MP0010155_abnormal_intestine_physiology | 0.84897760 |
| 112 | MP0002998_abnormal_bone_remodeling | 0.84628566 |
| 113 | MP0001800_abnormal_humoral_immune | 0.84573114 |
| 114 | MP0001501_abnormal_sleep_pattern | 0.82958490 |
| 115 | MP0001944_abnormal_pancreas_morphology | 0.82258793 |
| 116 | MP0005275_abnormal_skin_tensile | 0.81348310 |
| 117 | MP0000604_amyloidosis | 0.80466004 |
| 118 | MP0005671_abnormal_response_to | 0.80249255 |
| 119 | MP0000681_abnormal_thyroid_gland | 0.80134932 |
| 120 | MP0005409_darkened_coat_color | 0.80134150 |
| 121 | MP0002452_abnormal_antigen_presenting | 0.79572032 |
| 122 | MP0005670_abnormal_white_adipose | 0.79151784 |
| 123 | MP0003690_abnormal_glial_cell | 0.78987635 |
| 124 | MP0003183_abnormal_peptide_metabolism | 0.78937022 |
| 125 | MP0003075_altered_response_to | 0.78730110 |
| 126 | MP0004808_abnormal_hematopoietic_stem | 0.78462010 |
| 127 | MP0001663_abnormal_digestive_system | 0.77878477 |
| 128 | MP0002249_abnormal_larynx_morphology | 0.77817302 |
| 129 | MP0002896_abnormal_bone_mineralization | 0.75743773 |
| 130 | MP0000538_abnormal_urinary_bladder | 0.75617173 |
| 131 | MP0002177_abnormal_outer_ear | 0.75602676 |
| 132 | MP0002933_joint_inflammation | 0.75587803 |
| 133 | MP0002723_abnormal_immune_serum | 0.74603409 |
| 134 | MP0003795_abnormal_bone_structure | 0.74388553 |
| 135 | MP0002396_abnormal_hematopoietic_system | 0.74140517 |
| 136 | MP0005397_hematopoietic_system_phenotyp | 0.73711481 |
| 137 | MP0001545_abnormal_hematopoietic_system | 0.73711481 |
| 138 | MP0002693_abnormal_pancreas_physiology | 0.72775636 |
| 139 | MP0005248_abnormal_Harderian_gland | 0.72610527 |
| 140 | MP0001186_pigmentation_phenotype | 0.72044615 |
| 141 | MP0008875_abnormal_xenobiotic_pharmacok | 0.71724591 |
| 142 | MP0000631_abnormal_neuroendocrine_gland | 0.70447890 |
| 143 | MP0004272_abnormal_basement_membrane | 0.69464935 |
| 144 | MP0001845_abnormal_inflammatory_respons | 0.69236977 |
| 145 | MP0009115_abnormal_fat_cell | 0.68880483 |
| 146 | MP0009763_increased_sensitivity_to | 0.68308765 |
| 147 | MP0002928_abnormal_bile_duct | 0.67938564 |
| 148 | MP0003448_altered_tumor_morphology | 0.67840134 |
| 149 | MP0005535_abnormal_body_temperature | 0.66517653 |
| 150 | MP0002332_abnormal_exercise_endurance | 0.65407879 |
| 151 | MP0004484_altered_response_of | 0.61070332 |
| 152 | MP0009765_abnormal_xenobiotic_induced | 0.59023494 |
| 153 | MP0005076_abnormal_cell_differentiation | 0.58933138 |
| 154 | MP0002136_abnormal_kidney_physiology | 0.58630107 |
| 155 | MP0004130_abnormal_muscle_cell | 0.55407711 |
| 156 | MP0001986_abnormal_taste_sensitivity | 0.55333474 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Stomach cancer (HP:0012126) | 5.99723224 |
| 2 | Prostate neoplasm (HP:0100787) | 5.15063012 |
| 3 | Lip pit (HP:0100267) | 5.11464305 |
| 4 | Urethral obstruction (HP:0000796) | 4.95089509 |
| 5 | Stomatitis (HP:0010280) | 4.88702987 |
| 6 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.47410283 |
| 7 | Myositis (HP:0100614) | 4.41487886 |
| 8 | Abnormality of macrophages (HP:0004311) | 4.22241422 |
| 9 | Orchitis (HP:0100796) | 4.19493574 |
| 10 | Recurrent bacterial skin infections (HP:0005406) | 4.12528690 |
| 11 | Recurrent abscess formation (HP:0002722) | 3.96347795 |
| 12 | Mediastinal lymphadenopathy (HP:0100721) | 3.88586227 |
| 13 | Vasculitis (HP:0002633) | 3.80470658 |
| 14 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.63107332 |
| 15 | Increased IgE level (HP:0003212) | 3.57443845 |
| 16 | Recurrent fungal infections (HP:0002841) | 3.57394933 |
| 17 | Eczematoid dermatitis (HP:0000976) | 3.57257564 |
| 18 | Meningitis (HP:0001287) | 3.55818153 |
| 19 | Spontaneous hematomas (HP:0007420) | 3.53213941 |
| 20 | Distal lower limb muscle weakness (HP:0009053) | 3.48884338 |
| 21 | Alopecia of scalp (HP:0002293) | 3.48086973 |
| 22 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.44031480 |
| 23 | Gastrointestinal stroma tumor (HP:0100723) | 3.26287152 |
| 24 | Gastrointestinal infarctions (HP:0005244) | 3.24450384 |
| 25 | Pulmonary infiltrates (HP:0002113) | 3.20470442 |
| 26 | Keratoconjunctivitis sicca (HP:0001097) | 3.10064653 |
| 27 | Bifid scrotum (HP:0000048) | 3.08096796 |
| 28 | Increased CSF protein (HP:0002922) | 3.05652721 |
| 29 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.02008916 |
| 30 | Recurrent cutaneous fungal infections (HP:0011370) | 3.02008916 |
| 31 | Systemic lupus erythematosus (HP:0002725) | 2.99710882 |
| 32 | Recurrent viral infections (HP:0004429) | 2.99464839 |
| 33 | Ulnar claw (HP:0001178) | 2.99134244 |
| 34 | Growth hormone excess (HP:0000845) | 2.98452688 |
| 35 | Recurrent skin infections (HP:0001581) | 2.96775725 |
| 36 | Cupped ear (HP:0000378) | 2.90177313 |
| 37 | Alveolar cell carcinoma (HP:0006519) | 2.89590787 |
| 38 | Keratoconjunctivitis (HP:0001096) | 2.89024366 |
| 39 | Median cleft lip (HP:0000161) | 2.87444744 |
| 40 | Encephalitis (HP:0002383) | 2.87141966 |
| 41 | Hemoptysis (HP:0002105) | 2.80045687 |
| 42 | Cellulitis (HP:0100658) | 2.79542004 |
| 43 | Chronic obstructive pulmonary disease (HP:0006510) | 2.78341933 |
| 44 | Obstructive lung disease (HP:0006536) | 2.78341933 |
| 45 | Agammaglobulinemia (HP:0004432) | 2.78025728 |
| 46 | Colitis (HP:0002583) | 2.75095831 |
| 47 | Abnormality of the nasal septum (HP:0000419) | 2.74299802 |
| 48 | Panhypogammaglobulinemia (HP:0003139) | 2.73752235 |
| 49 | Inflammation of the large intestine (HP:0002037) | 2.73385850 |
| 50 | Upper limb muscle weakness (HP:0003484) | 2.72443867 |
| 51 | Abnormality of cochlea (HP:0000375) | 2.69483798 |
| 52 | Hematochezia (HP:0002573) | 2.68963863 |
| 53 | Aplasia involving bones of the extremities (HP:0009825) | 2.68713688 |
| 54 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.68713688 |
| 55 | Aplasia of the phalanges of the hand (HP:0009802) | 2.68713688 |
| 56 | Recurrent bronchitis (HP:0002837) | 2.68543017 |
| 57 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.66910565 |
| 58 | T lymphocytopenia (HP:0005403) | 2.66668619 |
| 59 | Abnormality of the prostate (HP:0008775) | 2.65955987 |
| 60 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.65729618 |
| 61 | Abnormality of T cell number (HP:0011839) | 2.63619320 |
| 62 | Lymphopenia (HP:0001888) | 2.61463972 |
| 63 | Leukocytosis (HP:0001974) | 2.61143058 |
| 64 | Urticaria (HP:0001025) | 2.60021558 |
| 65 | Gingivitis (HP:0000230) | 2.59349524 |
| 66 | Gastrointestinal inflammation (HP:0004386) | 2.58420909 |
| 67 | Autoimmune thrombocytopenia (HP:0001973) | 2.58258864 |
| 68 | Restrictive lung disease (HP:0002091) | 2.54305589 |
| 69 | Abnormality of the fingertips (HP:0001211) | 2.53678385 |
| 70 | Autoimmune hemolytic anemia (HP:0001890) | 2.52309848 |
| 71 | Episodic fever (HP:0001954) | 2.51138242 |
| 72 | Chest pain (HP:0100749) | 2.50852181 |
| 73 | Abnormality of T cells (HP:0002843) | 2.48967171 |
| 74 | Intestinal atresia (HP:0011100) | 2.48837818 |
| 75 | Fatigue (HP:0012378) | 2.48739704 |
| 76 | Down-sloping shoulders (HP:0200021) | 2.48698300 |
| 77 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.46997221 |
| 78 | Recurrent sinusitis (HP:0011108) | 2.46856140 |
| 79 | Papilledema (HP:0001085) | 2.46434679 |
| 80 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.46088573 |
| 81 | Pustule (HP:0200039) | 2.42568203 |
| 82 | Osteomyelitis (HP:0002754) | 2.42001561 |
| 83 | Sparse scalp hair (HP:0002209) | 2.39662286 |
| 84 | Abnormality of the pleura (HP:0002103) | 2.39200205 |
| 85 | Follicular hyperkeratosis (HP:0007502) | 2.37250305 |
| 86 | Abnormality of T cell physiology (HP:0011840) | 2.35948373 |
| 87 | Absent eyebrow (HP:0002223) | 2.34228043 |
| 88 | Prolonged bleeding time (HP:0003010) | 2.33683819 |
| 89 | Abnormality of the axillary hair (HP:0100134) | 2.32246854 |
| 90 | Abnormality of secondary sexual hair (HP:0009888) | 2.32246854 |
| 91 | Popliteal pterygium (HP:0009756) | 2.30448078 |
| 92 | Pulmonary embolism (HP:0002204) | 2.28889088 |
| 93 | Aplasia/Hypoplasia of the phalanges of the toes (HP:0010173) | 2.27963931 |
| 94 | Preauricular pit (HP:0004467) | 2.25575099 |
| 95 | Periauricular skin pits (HP:0100277) | 2.25575099 |
| 96 | Arterial thrombosis (HP:0004420) | 2.25445218 |
| 97 | Long clavicles (HP:0000890) | 2.25151601 |
| 98 | Emphysema (HP:0002097) | 2.24940243 |
| 99 | True hermaphroditism (HP:0010459) | 2.23560273 |
| 100 | Hypergammaglobulinemia (HP:0010702) | 2.22094946 |
| 101 | Joint swelling (HP:0001386) | 2.20867387 |
| 102 | Chronic diarrhea (HP:0002028) | 2.18778675 |
| 103 | Hyperactive renin-angiotensin system (HP:0000841) | 2.16400926 |
| 104 | Abnormality of the renal collecting system (HP:0004742) | 2.16322760 |
| 105 | Papilloma (HP:0012740) | 2.15600124 |
| 106 | Verrucae (HP:0200043) | 2.15600124 |
| 107 | Granulocytopenia (HP:0001913) | 2.14033461 |
| 108 | Dysostosis multiplex (HP:0000943) | 2.14014616 |
| 109 | Gangrene (HP:0100758) | 2.12756941 |
| 110 | Abnormality of male internal genitalia (HP:0000022) | 2.09946098 |
| 111 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.09630902 |
| 112 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.09630902 |
| 113 | Abnormality of glycolipid metabolism (HP:0010969) | 2.09630902 |
| 114 | Chronic otitis media (HP:0000389) | 2.08527639 |
| 115 | Congenital, generalized hypertrichosis (HP:0004540) | 2.08224636 |
| 116 | Amyloidosis (HP:0011034) | 2.07530659 |
| 117 | Onycholysis (HP:0001806) | 2.06866778 |
| 118 | Increased IgM level (HP:0003496) | 2.06697819 |
| 119 | Epistaxis (HP:0000421) | 2.05533846 |
| 120 | Milia (HP:0001056) | 2.04571105 |
| 121 | Peripheral hypomyelination (HP:0007182) | 2.04418219 |
| 122 | White forelock (HP:0002211) | 2.04414429 |
| 123 | Sepsis (HP:0100806) | 2.02510596 |
| 124 | Eosinophilia (HP:0001880) | 2.01944766 |
| 125 | Submucous cleft hard palate (HP:0000176) | 2.01890404 |
| 126 | Malnutrition (HP:0004395) | 2.01842241 |
| 127 | Glomerulonephritis (HP:0000099) | 2.00528694 |
| 128 | Hypoplastic scapulae (HP:0000882) | 1.99407145 |
| 129 | Aplasia/Hypoplasia of the scapulae (HP:0006713) | 1.99407145 |
| 130 | IgG deficiency (HP:0004315) | 1.99010643 |
| 131 | Arthralgia (HP:0002829) | 1.98217063 |
| 132 | Plantar hyperkeratosis (HP:0007556) | 1.97490440 |
| 133 | Osteomalacia (HP:0002749) | 1.96720785 |
| 134 | Vacuolated lymphocytes (HP:0001922) | 1.96484425 |
| 135 | Redundant skin (HP:0001582) | 1.96203484 |
| 136 | Hypoplastic labia majora (HP:0000059) | 1.95690529 |
| 137 | IgM deficiency (HP:0002850) | 1.95063817 |
| 138 | Loss of speech (HP:0002371) | 1.95055663 |
| 139 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.94631563 |
| 140 | Slow saccadic eye movements (HP:0000514) | 1.94023861 |
| 141 | Osteolytic defects of the hand bones (HP:0009699) | 1.92726768 |
| 142 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.92726768 |
| 143 | Thick nail (HP:0001805) | 1.92132428 |
| 144 | Cheilitis (HP:0100825) | 1.91550742 |
| 145 | Gastrointestinal atresia (HP:0002589) | 1.91401741 |
| 146 | Nasolacrimal duct obstruction (HP:0000579) | 1.90965295 |
| 147 | Increased cerebral lipofuscin (HP:0011813) | 1.90841123 |
| 148 | Abnormality of incisor morphology (HP:0011063) | 1.89127413 |
| 149 | Interstitial pulmonary disease (HP:0006530) | 1.88870002 |
| 150 | Renal cortical cysts (HP:0000803) | 1.88824923 |
| 151 | Gingival bleeding (HP:0000225) | 1.88427519 |
| 152 | Natal tooth (HP:0000695) | 1.87266515 |
| 153 | Acne (HP:0001061) | 1.86462225 |
| 154 | Cerebral palsy (HP:0100021) | 1.84935410 |
| 155 | Decreased circulating renin level (HP:0003351) | 1.84443528 |
| 156 | Patchy hypopigmentation of hair (HP:0011365) | 1.83887449 |
| 157 | Hypoplasia of the fovea (HP:0007750) | 1.82403422 |
| 158 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.82403422 |
| 159 | Hydroureter (HP:0000072) | 1.81794607 |
| 160 | Progressive visual loss (HP:0000529) | 1.81120065 |
| 161 | Atrophic scars (HP:0001075) | 1.81092577 |
| 162 | Symptomatic seizures (HP:0011145) | 1.79168883 |
| 163 | Congenital sensorineural hearing impairment (HP:0008527) | 1.76340495 |
| 164 | Hypoglycemic seizures (HP:0002173) | 1.75664668 |
| 165 | Morphological abnormality of the middle ear (HP:0008609) | 1.74060207 |
| 166 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.73966914 |
| 167 | Abnormality of the labia majora (HP:0012881) | 1.73940533 |
| 168 | Skin pits (HP:0100276) | 1.73569092 |
| 169 | Abnormality of the lacrimal duct (HP:0011481) | 1.72763082 |
| 170 | Abnormality of chloride homeostasis (HP:0011422) | 1.72387747 |
| 171 | Palmoplantar hyperkeratosis (HP:0000972) | 1.71644553 |
| 172 | Hypoplasia of the uterus (HP:0000013) | 1.70221672 |
| 173 | Right ventricular cardiomyopathy (HP:0011663) | 1.69615448 |
| 174 | Mucopolysacchariduria (HP:0008155) | 1.68200879 |
| 175 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.68200879 |
| 176 | Palmar hyperkeratosis (HP:0010765) | 1.67914918 |
| 177 | Abnormality of the nasolacrimal system (HP:0000614) | 1.66718258 |
| 178 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.66395642 |
| 179 | Dysautonomia (HP:0002459) | 1.65018304 |
| 180 | Male pseudohermaphroditism (HP:0000037) | 1.64829574 |
| 181 | Hyperglycemia (HP:0003074) | 1.64226900 |
| 182 | 11 pairs of ribs (HP:0000878) | 1.62689054 |
| 183 | Glomerulopathy (HP:0100820) | 1.62479044 |
| 184 | Neoplasm of the lung (HP:0100526) | 1.62356827 |
| 185 | Dry hair (HP:0011359) | 1.61807086 |
| 186 | Hypoplasia of dental enamel (HP:0006297) | 1.61354253 |
| 187 | Optic neuritis (HP:0100653) | 1.61211418 |
| 188 | Retrobulbar optic neuritis (HP:0100654) | 1.61211418 |
| 189 | Adactyly (HP:0009776) | 1.59689951 |
| 190 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.58258891 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAPK15 | 5.37648683 |
| 2 | MAP2K2 | 3.50399200 |
| 3 | MAP3K3 | 3.16007109 |
| 4 | RIPK4 | 3.10023490 |
| 5 | TGFBR2 | 2.46370262 |
| 6 | MAP3K14 | 2.38959419 |
| 7 | MAP3K2 | 2.27865919 |
| 8 | ERN1 | 2.27178188 |
| 9 | INSRR | 2.23574520 |
| 10 | ZAK | 2.21528078 |
| 11 | BLK | 2.17964296 |
| 12 | PDK2 | 2.15762411 |
| 13 | NEK6 | 2.05721206 |
| 14 | MAPK7 | 1.99939296 |
| 15 | IKBKB | 1.95400254 |
| 16 | TXK | 1.93132255 |
| 17 | HIPK2 | 1.77568008 |
| 18 | NLK | 1.75923837 |
| 19 | ERBB3 | 1.74886466 |
| 20 | EPHA3 | 1.72491050 |
| 21 | MAP3K13 | 1.64741684 |
| 22 | CHUK | 1.62156736 |
| 23 | FES | 1.53668036 |
| 24 | IKBKE | 1.52869392 |
| 25 | IRAK3 | 1.52682964 |
| 26 | MST4 | 1.49712394 |
| 27 | EPHA2 | 1.49465708 |
| 28 | TAOK2 | 1.48975991 |
| 29 | GRK7 | 1.47931629 |
| 30 | MAPKAPK5 | 1.43688080 |
| 31 | BMPR2 | 1.41526614 |
| 32 | TRPM7 | 1.41301389 |
| 33 | PRPF4B | 1.39272610 |
| 34 | SIK3 | 1.36538683 |
| 35 | BMPR1B | 1.36367919 |
| 36 | TAOK1 | 1.34594380 |
| 37 | FRK | 1.28559569 |
| 38 | CDK12 | 1.26596250 |
| 39 | SYK | 1.26498679 |
| 40 | HCK | 1.24711507 |
| 41 | CDK3 | 1.24383824 |
| 42 | GRK6 | 1.23756820 |
| 43 | ITK | 1.22317058 |
| 44 | ADRBK2 | 1.20900803 |
| 45 | VRK1 | 1.19172981 |
| 46 | RPS6KB2 | 1.11983552 |
| 47 | IRAK2 | 1.11608922 |
| 48 | CDK8 | 1.10288324 |
| 49 | NUAK1 | 1.07356884 |
| 50 | TEC | 1.06398030 |
| 51 | LYN | 1.06118509 |
| 52 | JAK2 | 1.05420059 |
| 53 | FER | 1.05219424 |
| 54 | SGK2 | 1.05106220 |
| 55 | SIK2 | 1.04595452 |
| 56 | TYK2 | 1.04301373 |
| 57 | IRAK4 | 1.01920621 |
| 58 | BRD4 | 1.00070831 |
| 59 | LCK | 0.99372173 |
| 60 | CASK | 0.94716497 |
| 61 | TSSK6 | 0.94425749 |
| 62 | CDC42BPA | 0.93945436 |
| 63 | MARK2 | 0.93687733 |
| 64 | IRAK1 | 0.92566472 |
| 65 | PASK | 0.92161822 |
| 66 | SIK1 | 0.92152548 |
| 67 | MAP2K3 | 0.91753062 |
| 68 | KIT | 0.91521653 |
| 69 | MAPKAPK2 | 0.91163830 |
| 70 | MARK3 | 0.91118083 |
| 71 | CSF1R | 0.89728912 |
| 72 | MAPK12 | 0.88272647 |
| 73 | RPS6KA2 | 0.87428368 |
| 74 | TIE1 | 0.86992031 |
| 75 | EPHB2 | 0.86381096 |
| 76 | RPS6KA6 | 0.85025222 |
| 77 | RPS6KC1 | 0.84903038 |
| 78 | RPS6KL1 | 0.84903038 |
| 79 | MAP3K7 | 0.84731721 |
| 80 | MAP3K11 | 0.84388369 |
| 81 | EPHB1 | 0.81825623 |
| 82 | STK10 | 0.81244935 |
| 83 | MATK | 0.78091306 |
| 84 | BTK | 0.77502280 |
| 85 | MAP3K10 | 0.76522796 |
| 86 | FGR | 0.76152464 |
| 87 | STK24 | 0.75976930 |
| 88 | NEK9 | 0.75493944 |
| 89 | PRKD2 | 0.74757002 |
| 90 | TRIB3 | 0.74694147 |
| 91 | PIM1 | 0.73649694 |
| 92 | RPS6KA5 | 0.72429595 |
| 93 | PIM2 | 0.70397615 |
| 94 | PDK1 | 0.67255261 |
| 95 | KSR2 | 0.65259214 |
| 96 | CAMKK1 | 0.64292086 |
| 97 | JAK1 | 0.63784967 |
| 98 | MAP2K1 | 0.62293865 |
| 99 | TGFBR1 | 0.60553738 |
| 100 | SGK3 | 0.59901431 |
| 101 | TBK1 | 0.59883715 |
| 102 | TNK2 | 0.59861622 |
| 103 | PRKCQ | 0.58999079 |
| 104 | EIF2AK2 | 0.58517816 |
| 105 | FGFR3 | 0.57925227 |
| 106 | MKNK2 | 0.57332518 |
| 107 | MAP4K1 | 0.56573927 |
| 108 | ZAP70 | 0.54816402 |
| 109 | PDPK1 | 0.54748426 |
| 110 | YES1 | 0.53995455 |
| 111 | GSK3A | 0.53641052 |
| 112 | SGK223 | 0.53469047 |
| 113 | SGK494 | 0.53469047 |
| 114 | CDK9 | 0.52779513 |
| 115 | TAOK3 | 0.51847541 |
| 116 | MAPK4 | 0.51324487 |
| 117 | * MAPK3 | 0.51119483 |
| 118 | FGFR4 | 0.51073391 |
| 119 | MYLK | 0.50887933 |
| 120 | RPS6KA4 | 0.50770282 |
| 121 | DMPK | 0.48315739 |
| 122 | GRK1 | 0.48078491 |
| 123 | RIPK1 | 0.47431029 |
| 124 | LMTK2 | 0.45904121 |
| 125 | PDGFRB | 0.45892190 |
| 126 | PRKCE | 0.44414335 |
| 127 | STK38L | 0.44259864 |
| 128 | DAPK2 | 0.44218700 |
| 129 | RPS6KA1 | 0.44123466 |
| 130 | MAP3K5 | 0.44076318 |
| 131 | PIK3CG | 0.43494531 |
| 132 | JAK3 | 0.42834841 |
| 133 | PIK3CA | 0.41517574 |
| 134 | CSK | 0.40933537 |
| 135 | MAPK11 | 0.39336168 |
| 136 | MAP3K1 | 0.39308168 |
| 137 | PRKG2 | 0.39274391 |
| 138 | MAP2K6 | 0.38811239 |
| 139 | CDK6 | 0.37691868 |
| 140 | LATS1 | 0.37524325 |
| 141 | DYRK1B | 0.35949810 |
| 142 | LRRK2 | 0.34267706 |
| 143 | STK11 | 0.33357529 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 4.33390117 |
| 2 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.66926912 |
| 3 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.66321883 |
| 4 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.49230771 |
| 5 | Allograft rejection_Homo sapiens_hsa05330 | 2.45408310 |
| 6 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.44682763 |
| 7 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.42468808 |
| 8 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.28592668 |
| 9 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.14132841 |
| 10 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.10047104 |
| 11 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.06680612 |
| 12 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.02203574 |
| 13 | Circadian rhythm_Homo sapiens_hsa04710 | 1.84448695 |
| 14 | Asthma_Homo sapiens_hsa05310 | 1.81748435 |
| 15 | Leishmaniasis_Homo sapiens_hsa05140 | 1.75755744 |
| 16 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.75193303 |
| 17 | Tuberculosis_Homo sapiens_hsa05152 | 1.66830670 |
| 18 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.61522728 |
| 19 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.58975212 |
| 20 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.54718354 |
| 21 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.53600925 |
| 22 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.47379667 |
| 23 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.43288985 |
| 24 | Viral myocarditis_Homo sapiens_hsa05416 | 1.33576419 |
| 25 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.32937547 |
| 26 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.31618108 |
| 27 | Protein export_Homo sapiens_hsa03060 | 1.28556182 |
| 28 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.27308185 |
| 29 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.24645472 |
| 30 | Retinol metabolism_Homo sapiens_hsa00830 | 1.23523348 |
| 31 | Galactose metabolism_Homo sapiens_hsa00052 | 1.23110095 |
| 32 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.22473109 |
| 33 | Prostate cancer_Homo sapiens_hsa05215 | 1.16776717 |
| 34 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.16411572 |
| 35 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.16102880 |
| 36 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.14964547 |
| 37 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.13870181 |
| 38 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.13315043 |
| 39 | Other glycan degradation_Homo sapiens_hsa00511 | 1.13132486 |
| 40 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.10562847 |
| 41 | Pertussis_Homo sapiens_hsa05133 | 1.08552920 |
| 42 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.07176860 |
| 43 | Prion diseases_Homo sapiens_hsa05020 | 1.03032842 |
| 44 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.01691445 |
| 45 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.01364346 |
| 46 | Adherens junction_Homo sapiens_hsa04520 | 1.00533134 |
| 47 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.97860986 |
| 48 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.97826351 |
| 49 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.96471969 |
| 50 | Legionellosis_Homo sapiens_hsa05134 | 0.95278912 |
| 51 | Apoptosis_Homo sapiens_hsa04210 | 0.95218930 |
| 52 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.94895033 |
| 53 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.94180832 |
| 54 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.92686943 |
| 55 | ABC transporters_Homo sapiens_hsa02010 | 0.91889424 |
| 56 | HTLV-I infection_Homo sapiens_hsa05166 | 0.91317457 |
| 57 | Hepatitis B_Homo sapiens_hsa05161 | 0.90687454 |
| 58 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.88807295 |
| 59 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.87783128 |
| 60 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.86780522 |
| 61 | Measles_Homo sapiens_hsa05162 | 0.86587683 |
| 62 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.86476305 |
| 63 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.85218194 |
| 64 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.84827405 |
| 65 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.84691560 |
| 66 | Influenza A_Homo sapiens_hsa05164 | 0.84444562 |
| 67 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.84054489 |
| 68 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.82819212 |
| 69 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.81057569 |
| 70 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.78225751 |
| 71 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.77930265 |
| 72 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.77486507 |
| 73 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.76854193 |
| 74 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.76498316 |
| 75 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.75741038 |
| 76 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.74995654 |
| 77 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.71863948 |
| 78 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.71386377 |
| 79 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.69680957 |
| 80 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.68896684 |
| 81 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.66960835 |
| 82 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.66430841 |
| 83 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.65406933 |
| 84 | Malaria_Homo sapiens_hsa05144 | 0.63945922 |
| 85 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.63863773 |
| 86 | Lysosome_Homo sapiens_hsa04142 | 0.61633792 |
| 87 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.61407283 |
| 88 | Shigellosis_Homo sapiens_hsa05131 | 0.61381178 |
| 89 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.59858100 |
| 90 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.58421437 |
| 91 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.58186319 |
| 92 | Cocaine addiction_Homo sapiens_hsa05030 | 0.57711626 |
| 93 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.57445197 |
| 94 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.57068601 |
| 95 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.56921799 |
| 96 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.56500422 |
| 97 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.56208590 |
| 98 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.55423980 |
| 99 | Hepatitis C_Homo sapiens_hsa05160 | 0.55303414 |
| 100 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.54829522 |
| 101 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.54391226 |
| 102 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.54170711 |
| 103 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.53684276 |
| 104 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.52618600 |
| 105 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.52377317 |
| 106 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.52313403 |
| 107 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.50863572 |
| 108 | Colorectal cancer_Homo sapiens_hsa05210 | 0.49913567 |
| 109 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.49907627 |
| 110 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.49220744 |
| 111 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.49193729 |
| 112 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.48067081 |
| 113 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.48041793 |
| 114 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.46750841 |
| 115 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.45274402 |
| 116 | Thyroid cancer_Homo sapiens_hsa05216 | 0.45133214 |
| 117 | Insulin resistance_Homo sapiens_hsa04931 | 0.45021879 |
| 118 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.44700623 |
| 119 | Pathways in cancer_Homo sapiens_hsa05200 | 0.42579002 |
| 120 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.41871158 |
| 121 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.41756618 |
| 122 | Endometrial cancer_Homo sapiens_hsa05213 | 0.40794633 |
| 123 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.40780018 |
| 124 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.40458155 |
| 125 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.40062776 |
| 126 | Salmonella infection_Homo sapiens_hsa05132 | 0.39366238 |
| 127 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.38844705 |
| 128 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.38810880 |
| 129 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.38546039 |
| 130 | Amoebiasis_Homo sapiens_hsa05146 | 0.37568982 |
| 131 | Phagosome_Homo sapiens_hsa04145 | 0.36739635 |
| 132 | Insulin secretion_Homo sapiens_hsa04911 | 0.36024493 |
| 133 | Platelet activation_Homo sapiens_hsa04611 | 0.35685371 |
| 134 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.34910159 |
| 135 | Endocytosis_Homo sapiens_hsa04144 | 0.31438980 |

